Mainz Biomed Announces Stock Split
1. Mainz Biomed announces a 1-for-40 reverse stock split on November 29, 2024. 2. The split aims to comply with Nasdaq's minimum bid price requirements. 3. Post-split, shares will reduce from 80.1 million to approximately 2.0 million. 4. Failure to meet compliance could affect future listing on Nasdaq. 5. The company still seeks to regain compliance following a Nasdaq determination letter.